Neuroendocrine Carcinoma Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
Advanced Neuroendocrine Carcinoma
Nanjing Leads Biolabs Co.,Ltd178 enrolled25 locationsNCT06157827
Recruiting
Phase 1Phase 2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd78 enrolled1 locationNCT06440057
Recruiting
Phase 1Phase 2
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd93 enrolled1 locationNCT06372626
Recruiting
Phase 2
First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma
Gastrointestinal Neuroendocrine Carcinoma
Peking Union Medical College Hospital22 enrolled1 locationNCT06070740